Pfizer Wins Discovery Spat In Lipitor Off-Market Suit

Pfizer Inc. has scored a win in a fight over discovery in a case involving 11 ERISA benefit funds that claimed the drug maker improperly marketed its blockbuster cholesterol treatment Lipitor...

Already a subscriber? Click here to view full article